SpainSpain

Biosensor to Avoid Allergies

07.06.2004

Tarragona - The University of Rovira i Virgili (Spain) and seven other European partners have recently joined the development of an biosensor within the EU project “CD-CHEF”. The sensor is able to detect gluten in food which triggers allergic reactions in humans.
The biosensor is located on a miniaturised disposable chip made of a polymeric material. The chip is designed for a modular kit which later controls sample processing, dosage and analysis. The electrochemi-cal detection of allergenic gluten relies on ampero-metrics. Two electrodes are employed: A micro-reference electrode with a solid electrolyte made of silver/silver chloride and a modified gold film. The gold film is coated with specific antibodies that specifically bind allergenic gluten. The bonding triggers an electrochemical reaction. With the current flow inherent in this reaction gluten can be quantitatively detected.
The analysis chip is designated for food control by manufacturers who want to declare their goods gluten-free. At the same time, the biochip will set an EU standard for the detection and extraction of gluten in food.
The project (QLKI-2002-02077) is EU funded by the “Quality of Life” programme.

SpainSpain

20.10.2008

Most industry experts would agree that the Spanish biotech industry really only got rolling about a decade ago, particularly if you don’t count exceptions like PharmaMar, which was founded in 1986 as a fully-owned spin-out of...

SpainSpain

22.09.2008

Madrid – Spanish researchers have added a new model to the origin of tumour metastasis, the most common form of cancer death. In September, the team under Prof. Manuel Esteller from the Spanish National Cancer Research Center in...

SpainSpain

18.08.2008

Madrid – Spain’s health ministry has launched a a16m fund to support the development of orphan and pediatric drugs. The money will be distributed by the Carlos III Health Institute, and is dedicated to clinical projects of minor...

SpainSpain

18.08.2008

Barcelona – A chitosan-based delivery system for cyclosporin has shown promising results in a Phase I/II study with 25 psoriasis patients, according to a June report from its developer, Spanish biotech firm Advancell.

SpainSpain

14.08.2008

Madrid – Biotechnology is taking off in Spain. In 2007, there were 659 companies with biotech activities in the country, generating EUR22,500 million and employing more than 88,000 people (+38% up on 2005), according to the...

SpainSpain

18.06.2008

A Madrid – About 70% of all women will become infected with papilloma viruses (HPV) at least once in their lifetime. Now, the Spanish vaccine specialist Chimera Pharma SL (Madrid) has signed an exclusive licensing and cooperation...

SpainSpain

20.05.2008

The commercialisation of scientific results is not thought to be one of Spain’s strengths, but major changes have been underway in recent years, especially in the area of biotechnology. Supported by the government, the new...

SpainSpain

20.05.2008

Valencia/Madrid – Ysios Capital Partners has gotten the go-ahead from the Commission Nacional del Mercado de Valores (CNMV) to create a venture capital fund with assets totalling €65m – €75m dedicated exclusively to the...

SpainSpain

20.05.2008

Madrid – The former president of the Spanish biotechnology association Asebio and CEO of Genetrix Group, Christina Garmendia, will lead Spain’s newly created Ministry of Science and Innovation. Garmendia assumed her duties as...

SpainSpain

31.03.2008

Valencia/Madrid – Researchers from the Prince Felipe Research Centre in Valencia (CIPF) have gotten the go-ahead from the Commission for Monitoring, Control and Use of Human Tissues and Cells Carlos III Health Institute to...

Displaying results 61 to 70 out of 181

< Previous 61-70 Next >

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-spain/browse/6/article/biosensor-to-avoid-allergies.html

Video

All videos

Product of the week

Products

WhitePaper

LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...

Events

All Events

Partner-Events

München

BioVaria 2015

Job Advert

Sales Manager

celares GmbH is a Berlin based drug delivery company focused on chemical modifications of biological drugs. We offer customized development services for international pharma and biopharma companies and have manufacturing capabilities for key starting materials used for the preparation of pharmaceutical drugs. For the intensification of our own sales activities we are looking for a sales manager. more...

Stock list

All quotes

TOP

  • CO.DON2.97 EUR2.41%
  • MOLOGEN5.06 EUR0.80%
  • CYTOS1.28 CHF0.79%

FLOP

  • MEDIGENE12.90 EUR-11.03%
  • 4SC1.18 EUR-5.60%
  • PAION2.37 EUR-5.58%

TOP

  • 4SC1.18 EUR71.0%
  • MEDIGENE12.90 EUR63.9%
  • FORMYCON31.00 EUR31.1%

FLOP

  • MORPHOSYS60.74 EUR-13.0%
  • BB BIOTECH281.20 EUR-11.2%
  • EPIGENOMICS5.31 EUR-10.6%

TOP

  • SANTHERA99.75 CHF2709.9%
  • CYTOS1.28 CHF652.9%
  • FORMYCON31.00 EUR336.6%

FLOP

  • MOLOGEN5.06 EUR-53.1%
  • PAION2.37 EUR-22.3%
  • BIOFRONTERA2.57 EUR-21.2%

No liability assumed, Date: 18.04.2015

Current issue

All issues